The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Inhalable Drugs Market Research Report 2024

Global Inhalable Drugs Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1415253

No of Pages : 92

Ask Your Query

Synopsis

Inhalable drugs are medicines that inhaled directly into lungs to achieve higher curing efficiency.

Global Inhalable Drugs market is projected to reach US$ 27980 million in 2029, increasing from US$ 21830 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Inhalable Drugs market research.

Global inhalable drugs market is expected to witness a lucrative market growth over the forecast period owing to rising prevalence of chronic diseases such as diabetes mellitus, tuberculosis, cancer and increasing geriatric population base which requires more convenient route of administration.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Inhalable Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     NanoDerma
  •     Pfizer
  •     Aradigm Corporation
  •     Alkerme
  •     Dura Pharmaceuticals
  •     AeroGen and Inhale Therapeutic Systems

Segment by Type

  •     Suspension Aerosol
  •     Solution Aerosol
  •     Dry Powder Formulation

Segment by Application

  •     Respiratory Diseases
  •     Non-respiratory Diseases

Consumption by Region

  •   North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Inhalable Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

 1.1 Product Overview and Scope of Inhalable Drugs
    1.2 Inhalable Drugs Segment by Type
        1.2.1 Global Inhalable Drugs Market Value Comparison by Type (2023-2029)
        1.2.2 Suspension Aerosol
        1.2.3 Solution Aerosol
        1.2.4 Dry Powder Formulation
    1.3 Inhalable Drugs Segment by Application
        1.3.1 Global Inhalable Drugs Market Value by Application: (2023-2029)
        1.3.2 Respiratory Diseases
        1.3.3 Non-respiratory Diseases
    1.4 Global Inhalable Drugs Market Size Estimates and Forecasts
        1.4.1 Global Inhalable Drugs Revenue 2018-2029
        1.4.2 Global Inhalable Drugs Sales 2018-2029
        1.4.3 Global Inhalable Drugs Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Inhalable Drugs Market Competition by Manufacturers
    2.1 Global Inhalable Drugs Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Inhalable Drugs Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Inhalable Drugs Average Price by Manufacturers (2018-2023)
    2.4 Global Inhalable Drugs Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Inhalable Drugs, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Inhalable Drugs, Product Type & Application
    2.7 Inhalable Drugs Market Competitive Situation and Trends
        2.7.1 Inhalable Drugs Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Inhalable Drugs Players Market Share by Revenue
        2.7.3 Global Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Inhalable Drugs Retrospective Market Scenario by Region
    3.1 Global Inhalable Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Inhalable Drugs Global Inhalable Drugs Sales by Region: 2018-2029
        3.2.1 Global Inhalable Drugs Sales by Region: 2018-2023
        3.2.2 Global Inhalable Drugs Sales by Region: 2024-2029
    3.3 Global Inhalable Drugs Global Inhalable Drugs Revenue by Region: 2018-2029
        3.3.1 Global Inhalable Drugs Revenue by Region: 2018-2023
        3.3.2 Global Inhalable Drugs Revenue by Region: 2024-2029
    3.4 North America Inhalable Drugs Market Facts & Figures by Country
        3.4.1 North America Inhalable Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Inhalable Drugs Sales by Country (2018-2029)
        3.4.3 North America Inhalable Drugs Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Inhalable Drugs Market Facts & Figures by Country
        3.5.1 Europe Inhalable Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Inhalable Drugs Sales by Country (2018-2029)
        3.5.3 Europe Inhalable Drugs Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Inhalable Drugs Market Facts & Figures by Country
        3.6.1 Asia Pacific Inhalable Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Inhalable Drugs Sales by Country (2018-2029)
        3.6.3 Asia Pacific Inhalable Drugs Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Inhalable Drugs Market Facts & Figures by Country
        3.7.1 Latin America Inhalable Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Inhalable Drugs Sales by Country (2018-2029)
        3.7.3 Latin America Inhalable Drugs Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Inhalable Drugs Market Facts & Figures by Country
        3.8.1 Middle East and Africa Inhalable Drugs Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Inhalable Drugs Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Inhalable Drugs Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Inhalable Drugs Sales by Type (2018-2029)
        4.1.1 Global Inhalable Drugs Sales by Type (2018-2023)
        4.1.2 Global Inhalable Drugs Sales by Type (2024-2029)
        4.1.3 Global Inhalable Drugs Sales Market Share by Type (2018-2029)
    4.2 Global Inhalable Drugs Revenue by Type (2018-2029)
        4.2.1 Global Inhalable Drugs Revenue by Type (2018-2023)
        4.2.2 Global Inhalable Drugs Revenue by Type (2024-2029)
        4.2.3 Global Inhalable Drugs Revenue Market Share by Type (2018-2029)
    4.3 Global Inhalable Drugs Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Inhalable Drugs Sales by Application (2018-2029)
        5.1.1 Global Inhalable Drugs Sales by Application (2018-2023)
        5.1.2 Global Inhalable Drugs Sales by Application (2024-2029)
        5.1.3 Global Inhalable Drugs Sales Market Share by Application (2018-2029)
    5.2 Global Inhalable Drugs Revenue by Application (2018-2029)
        5.2.1 Global Inhalable Drugs Revenue by Application (2018-2023)
        5.2.2 Global Inhalable Drugs Revenue by Application (2024-2029)
        5.2.3 Global Inhalable Drugs Revenue Market Share by Application (2018-2029)
    5.3 Global Inhalable Drugs Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 NanoDerma
        6.1.1 NanoDerma Corporation Information
        6.1.2 NanoDerma Description and Business Overview
        6.1.3 NanoDerma Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 NanoDerma Inhalable Drugs Product Portfolio
        6.1.5 NanoDerma Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Pfizer Inhalable Drugs Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Aradigm Corporation
        6.3.1 Aradigm Corporation Corporation Information
        6.3.2 Aradigm Corporation Description and Business Overview
        6.3.3 Aradigm Corporation Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Aradigm Corporation Inhalable Drugs Product Portfolio
        6.3.5 Aradigm Corporation Recent Developments/Updates
    6.4 Alkerme
        6.4.1 Alkerme Corporation Information
        6.4.2 Alkerme Description and Business Overview
        6.4.3 Alkerme Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Alkerme Inhalable Drugs Product Portfolio
        6.4.5 Alkerme Recent Developments/Updates
    6.5 Dura Pharmaceuticals
        6.5.1 Dura Pharmaceuticals Corporation Information
        6.5.2 Dura Pharmaceuticals Description and Business Overview
        6.5.3 Dura Pharmaceuticals Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Dura Pharmaceuticals Inhalable Drugs Product Portfolio
        6.5.5 Dura Pharmaceuticals Recent Developments/Updates
    6.6 AeroGen and Inhale Therapeutic Systems
        6.6.1 AeroGen and Inhale Therapeutic Systems Corporation Information
        6.6.2 AeroGen and Inhale Therapeutic Systems Description and Business Overview
        6.6.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product Portfolio
        6.6.5 AeroGen and Inhale Therapeutic Systems Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Inhalable Drugs Industry Chain Analysis
    7.2 Inhalable Drugs Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Inhalable Drugs Production Mode & Process
    7.4 Inhalable Drugs Sales and Marketing
        7.4.1 Inhalable Drugs Sales Channels
        7.4.2 Inhalable Drugs Distributors
    7.5 Inhalable Drugs Customers

 8 Inhalable Drugs Market Dynamics
    8.1 Inhalable Drugs Industry Trends
    8.2 Inhalable Drugs Market Drivers
    8.3 Inhalable Drugs Market Challenges
    8.4 Inhalable Drugs Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock